For research use only. We do not sell to patients.
Name | XMD17-109 |
---|---|
Iupac Chemical Name | 11-cyclopentyl-2-[[2-ethoxy-4-[[4-(4-Methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]aMino]-5,11-dihydro-5-Methyl-6H-PyriMido[4,5-b][1,4]benzodiazepin-6-one |
Synonyms | XMD17 109 |
Molecular Formula | C36H46N8O3 |
Molecular Weight | 638.8 |
Smile | C1(CCCC1)N1C2=C(N(C(C3=C1C=CC=C3)=O)C)C=NC(=N2)NC2=C(C=C(C=C2)C(=O)N2CCC(CC2)N2CCN(CC2)C)OCC |
InChiKey | XVBGRTMNFNMINE-UHFFFAOYSA-N |
InChi | InChI=1S/C36H46N8O3/c1-4-47-32-23-25(34(45)43-17-15-26(16-18-43)42-21-19-40(2)20-22-42)13-14-29(32)38-36-37-24-31-33(39-36)44(27-9-5-6-10-27)30-12-8-7-11-28(30)35(46)41(31)3/h7-8,11-14,23-24,26-27H,4-6,9-10,15-22H2,1-3H3,(H,37,38,39) |
CAS Number | 1435488-37-1 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% by HPLC |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |